<div id="readability-page-1"><div> <p>DAMAI ENT (01060.HK)<span> </span><span> -0.040 (-6.250%)  </span> <span> Short selling $44.07M; Ratio 30.051%  </span>  announced its full-year results for the year ended end-March this year. Revenue rose 19.7% YoY to RMB8.024 billion. Net profit surged 94% YoY to RMB705 million, with EPS at RMB0.0238. No dividend was declared.<br/></p><br/>During the period, adjusted EBITA declined 7.8% YoY to RMB746 million.<p>DAMAI ENT opened 1.56% lower today, hitting an intraday trough of HKD0.58. It is now trading at HKD0.59, down 7.81%, with 143 million shares traded, involving HKD86.0011 million in turnover. (sl/a)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-27 16:25.)</p><p>AASTOCKS Financial News</p> </div></div>

01060

<p>DAMAI ENTshares fell nearly 8% after announcing its full-year results, with adjusted EBITA declining 7.8% YoY to RMB746 million. Despite a 19.7% increase in revenue to RMB8.024 billion and a 94% rise in net profit to RMB705 million, no dividend was declared. The stock opened 1.56% lower and is currently trading at HKD0.59.</p>

DAMAI ENT Slumps Nearly 8% as Full-Year Adjusted EBITA Falls 7.8%